Emergent BioSolutions (EBS) Gross Margin (2011 - 2026)
Emergent BioSolutions (EBS) posted Gross Margin of 58.56% for Q2 2026, up 6.04 percentage points from 52.52% a year earlier and up 4.68 percentage points from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Gross Margin (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Margin at Emergent BioSolutions was 55.87%, up 2.37 percentage points year-over-year; for FY2025, it came in at 56.09%, up 21.37 percentage points from FY2024.
- Annual Gross Margin shows a five-year change of -9.86 percentage points (FY2020 to FY2025).
- In prior years, Emergent BioSolutions' Gross Margin was 34.72% in FY2024 (+1.94 pp), 32.77% in FY2023 (-5.20 pp), 37.98% in FY2022 (-19.84 pp) and 57.82% in FY2021 (-8.13 pp).
- Quarterly Gross Margin has run from a low of -16.25% in Q2 2024 to a high of 72.23% in Q4 2021 over five years.
- On a year-over-year basis, Gross Margin increased in seven of the last eight quarters, with an average year-over-year change of +14.35 percentage points.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q2 2025, with a gain of 68.77 percentage points; the weakest was Q2 2024, with a drop of 59.85 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 53.88% (Q1 2026), 42.91% (Q4 2025) and 62.83% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,143.32 Bn | 1,111.90 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 622.51 Bn | 541.03 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 510.50 Bn | 483.61 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 366.44 Bn | 320.81 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 297.34 Bn | 261.33 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 261.26 Bn | 234.95 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 234.60 Bn | 190.00 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 193.91 Bn | 168.11 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 172.02 Bn | 118.67 Bn | 10.94 Bn | 72.78% |
| 10 | Emergent BioSolutions | 321.47 Mn | -429.43 Mn | 137.20 Mn | 58.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 58.56% |
| Mar 31, 2026 | 53.88% |
| Dec 31, 2025 | 42.91% |
| Sep 30, 2025 | 62.83% |
| Jun 30, 2025 | 52.52% |
| Mar 31, 2025 | 60.17% |
| Dec 31, 2024 | 39.39% |
| Sep 30, 2024 | 58.27% |
| Jun 30, 2024 | -16.25% |
| Mar 31, 2024 | 51.86% |
| Dec 31, 2023 | 33.08% |
| Sep 30, 2023 | 34.64% |
| Jun 30, 2023 | 43.59% |
| Mar 31, 2023 | 6.94% |
| Dec 31, 2022 | 33.22% |
| Sep 30, 2022 | 38.64% |
| Jun 30, 2022 | 30.01% |
| Mar 31, 2022 | 48.85% |
| Dec 31, 2021 | 72.23% |
| Sep 30, 2021 | 36.50% |
API Access
Emergent BioSolutions Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();